Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive and prognostic molecular biomarkers in lymphomas.

Pathology - 1 Mar 2024

Iorgulescu J Bryan, Medeiros L Jeffrey, Patel Keyur P

Abstract excerpt

Recent advances in molecular diagnostics have markedly expanded our understanding of the genetic underpinnings of lymphomas and catalysed a transformation in not just how we classify lymphomas, but also how we treat, target, and monitor affected patients. Reflecting these advances, the World Health Organization Classification, International Consensus Classification, and National Comprehensive Cancer Network...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lymphoma
Share to Lymphoma, B-Cell
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Source

Identifiers

PMID: 38216400
DOI: 10.1016/j.pathol.2023.12.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive and prognostic molecular biomarkers in lymphomas.PMID 38216400Read ↗

Diagnostic and prognostic molecular pathology of lymphoid malignancies.Semantic proximity Read ↗

Molecular Monitoring of Lymphomas.Semantic proximity Read ↗

A genetic profiling guideline to support diagnosis and clinical management of lymphomas.Semantic proximity Read ↗

Precision diagnostics in lymphomas - Recent developments and future directions.Semantic proximity Read ↗

Exploiting gene mutations and biomarkers to guide treatment recommendations in mantle cell lymphoma.Semantic proximity Read ↗

Pathology of B-cell lymphomas: diagnosis and biomarker discovery.Semantic proximity Read ↗

NCCN task force report: molecular markers in leukemias and lymphomas.Semantic proximity Read ↗

Towards precision medicine in lymphoid malignanciesSemantic proximity Read ↗

Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy.Semantic proximity Read ↗

Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.Semantic proximity Read ↗

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsSemantic proximity Read ↗

Genomic profiling for clinical decision making in lymphoid neoplasmsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.